Effects of age and age of onset on prescribed antipsychotic dose in schizophrenia spectrum disorders

A survey of 1,418 patients in Japan

Hiroyuki Uchida, Takefumi Suzuki, David C. Mamo, Benoit H. Mulsant, Akira Tanabe, Ataru Inagaki, Koichiro Watanabe, Gohei Yagi, Masayuki Tomita

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

The relationship between age and prescribed antipsychotic dose in patients with schizophrenia has been examined by assuming only a linear correlation in two age subgroups at most. The age of illness onset has also not been under adequate consideration in past prescription surveys. The objective of this study was to better evaluate these age effects on antipsychotic dose prescribed in these patients across a broad age range. Methods: Review of prescriptions for antipsychotic medications in patients with schizophrenia spectrum disorders was conducted across 30 sites in Tokyo. A total of 1,418patients (655 inpatients, 763 males, age range: 16.6-90.2 years) were studied. Results: Age had significant effects on prescribed antipsychotic dose; the dose increased with age through the third decade, subsequently plateaued, and decreased after the fifth decade. The age of illness onset also had significant effects on the dose; late-onset schizophrenia (LOS) and very-late-onset schizophrenia-like psychoses (VLOS) patients received lower doses than early onset schizophrenia (EOS) patients. LOS and VLOS patients who did not experience any hospitalization for the previous year were treated with 1/2 and 1/3, respectively, of the dose for EOS of comparable current age. Conclusion: Our results suggested biphasic effects of age on antipsychotic dose prescribed in patients with schizophrenia spectrum disorders. The natural history of schizophrenia and physiological aging may contribute to this inverted U-shaped relationship. In addition, our results may add another evidence of dis-ttnction among EOS, LOS, and VLOS from a clinical psychopharmacological perspective.

Original languageEnglish
Pages (from-to)584-593
Number of pages10
JournalAmerican Journal of Geriatric Psychiatry
Volume16
Issue number7
DOIs
Publication statusPublished - 2008 Jul
Externally publishedYes

Fingerprint

Age of Onset
Antipsychotic Agents
Schizophrenia
Japan
Prescriptions
Surveys and Questionnaires
Tokyo
Psychotic Disorders
Inpatients
Hospitalization

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Medicine(all)

Cite this

Effects of age and age of onset on prescribed antipsychotic dose in schizophrenia spectrum disorders : A survey of 1,418 patients in Japan. / Uchida, Hiroyuki; Suzuki, Takefumi; Mamo, David C.; Mulsant, Benoit H.; Tanabe, Akira; Inagaki, Ataru; Watanabe, Koichiro; Yagi, Gohei; Tomita, Masayuki.

In: American Journal of Geriatric Psychiatry, Vol. 16, No. 7, 07.2008, p. 584-593.

Research output: Contribution to journalArticle

Uchida, Hiroyuki ; Suzuki, Takefumi ; Mamo, David C. ; Mulsant, Benoit H. ; Tanabe, Akira ; Inagaki, Ataru ; Watanabe, Koichiro ; Yagi, Gohei ; Tomita, Masayuki. / Effects of age and age of onset on prescribed antipsychotic dose in schizophrenia spectrum disorders : A survey of 1,418 patients in Japan. In: American Journal of Geriatric Psychiatry. 2008 ; Vol. 16, No. 7. pp. 584-593.
@article{3499b1de55174b1f815f9d8dd01bf677,
title = "Effects of age and age of onset on prescribed antipsychotic dose in schizophrenia spectrum disorders: A survey of 1,418 patients in Japan",
abstract = "The relationship between age and prescribed antipsychotic dose in patients with schizophrenia has been examined by assuming only a linear correlation in two age subgroups at most. The age of illness onset has also not been under adequate consideration in past prescription surveys. The objective of this study was to better evaluate these age effects on antipsychotic dose prescribed in these patients across a broad age range. Methods: Review of prescriptions for antipsychotic medications in patients with schizophrenia spectrum disorders was conducted across 30 sites in Tokyo. A total of 1,418patients (655 inpatients, 763 males, age range: 16.6-90.2 years) were studied. Results: Age had significant effects on prescribed antipsychotic dose; the dose increased with age through the third decade, subsequently plateaued, and decreased after the fifth decade. The age of illness onset also had significant effects on the dose; late-onset schizophrenia (LOS) and very-late-onset schizophrenia-like psychoses (VLOS) patients received lower doses than early onset schizophrenia (EOS) patients. LOS and VLOS patients who did not experience any hospitalization for the previous year were treated with 1/2 and 1/3, respectively, of the dose for EOS of comparable current age. Conclusion: Our results suggested biphasic effects of age on antipsychotic dose prescribed in patients with schizophrenia spectrum disorders. The natural history of schizophrenia and physiological aging may contribute to this inverted U-shaped relationship. In addition, our results may add another evidence of dis-ttnction among EOS, LOS, and VLOS from a clinical psychopharmacological perspective.",
author = "Hiroyuki Uchida and Takefumi Suzuki and Mamo, {David C.} and Mulsant, {Benoit H.} and Akira Tanabe and Ataru Inagaki and Koichiro Watanabe and Gohei Yagi and Masayuki Tomita",
year = "2008",
month = "7",
doi = "10.1097/JGP.0b013e318172b42d",
language = "English",
volume = "16",
pages = "584--593",
journal = "American Journal of Geriatric Psychiatry",
issn = "1064-7481",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Effects of age and age of onset on prescribed antipsychotic dose in schizophrenia spectrum disorders

T2 - A survey of 1,418 patients in Japan

AU - Uchida, Hiroyuki

AU - Suzuki, Takefumi

AU - Mamo, David C.

AU - Mulsant, Benoit H.

AU - Tanabe, Akira

AU - Inagaki, Ataru

AU - Watanabe, Koichiro

AU - Yagi, Gohei

AU - Tomita, Masayuki

PY - 2008/7

Y1 - 2008/7

N2 - The relationship between age and prescribed antipsychotic dose in patients with schizophrenia has been examined by assuming only a linear correlation in two age subgroups at most. The age of illness onset has also not been under adequate consideration in past prescription surveys. The objective of this study was to better evaluate these age effects on antipsychotic dose prescribed in these patients across a broad age range. Methods: Review of prescriptions for antipsychotic medications in patients with schizophrenia spectrum disorders was conducted across 30 sites in Tokyo. A total of 1,418patients (655 inpatients, 763 males, age range: 16.6-90.2 years) were studied. Results: Age had significant effects on prescribed antipsychotic dose; the dose increased with age through the third decade, subsequently plateaued, and decreased after the fifth decade. The age of illness onset also had significant effects on the dose; late-onset schizophrenia (LOS) and very-late-onset schizophrenia-like psychoses (VLOS) patients received lower doses than early onset schizophrenia (EOS) patients. LOS and VLOS patients who did not experience any hospitalization for the previous year were treated with 1/2 and 1/3, respectively, of the dose for EOS of comparable current age. Conclusion: Our results suggested biphasic effects of age on antipsychotic dose prescribed in patients with schizophrenia spectrum disorders. The natural history of schizophrenia and physiological aging may contribute to this inverted U-shaped relationship. In addition, our results may add another evidence of dis-ttnction among EOS, LOS, and VLOS from a clinical psychopharmacological perspective.

AB - The relationship between age and prescribed antipsychotic dose in patients with schizophrenia has been examined by assuming only a linear correlation in two age subgroups at most. The age of illness onset has also not been under adequate consideration in past prescription surveys. The objective of this study was to better evaluate these age effects on antipsychotic dose prescribed in these patients across a broad age range. Methods: Review of prescriptions for antipsychotic medications in patients with schizophrenia spectrum disorders was conducted across 30 sites in Tokyo. A total of 1,418patients (655 inpatients, 763 males, age range: 16.6-90.2 years) were studied. Results: Age had significant effects on prescribed antipsychotic dose; the dose increased with age through the third decade, subsequently plateaued, and decreased after the fifth decade. The age of illness onset also had significant effects on the dose; late-onset schizophrenia (LOS) and very-late-onset schizophrenia-like psychoses (VLOS) patients received lower doses than early onset schizophrenia (EOS) patients. LOS and VLOS patients who did not experience any hospitalization for the previous year were treated with 1/2 and 1/3, respectively, of the dose for EOS of comparable current age. Conclusion: Our results suggested biphasic effects of age on antipsychotic dose prescribed in patients with schizophrenia spectrum disorders. The natural history of schizophrenia and physiological aging may contribute to this inverted U-shaped relationship. In addition, our results may add another evidence of dis-ttnction among EOS, LOS, and VLOS from a clinical psychopharmacological perspective.

UR - http://www.scopus.com/inward/record.url?scp=50349095100&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50349095100&partnerID=8YFLogxK

U2 - 10.1097/JGP.0b013e318172b42d

DO - 10.1097/JGP.0b013e318172b42d

M3 - Article

VL - 16

SP - 584

EP - 593

JO - American Journal of Geriatric Psychiatry

JF - American Journal of Geriatric Psychiatry

SN - 1064-7481

IS - 7

ER -